medigraphic.com
ISSN 1870-199X (Print)
Órgano oficial de la Facultad de Odontología, UNAM

2009, Number 1

<< Back Next >>

Rev Odont Mex 2009; 13 (1)

Orodental findings of HIV+/AIDS long term survivors perinatally infected children

Alcántara G, Pavía N, Muñoz R, Gaitán LA

Language: Spanish
References: 26
Page: 37-42
PDF size: 162.23 Kb.


ABSTRACT

HIV+/AIDS perinatally infected children show two patterns of progression: rapid progressors (early development of AIDS, survival £ 2 years) and slow progressors (delayed development of AIDS, survival ³ 3 years). In this last group it has been identified a subpopulation: long term survivors (delayed clinical manifestations and greater survival). The oral and dental characteristics of this subpopulation are unknown. Objective: To describe the oral and dental characteristics of HIV+/AIDS long term survivors children. Material and methods: 56 children HIV+/AIDS (Immunodeficiency Clinic, Medicine Faculty, UNAM) were orally examined. According to their age, they were divided in: Slow progressors (3-8 years). This group was subdivided in pre-teenagers (of 8-12 years) and teenagers (13 years). The DMFT/dmft and the Simplified Oral Hygiene Index were established, following the criteria proposed by the WHO. The prevalence of oral lesions associated to HIV (OL-HIV) was also established (diagnosis criteria: EC Clearinghouse CDC-WHO), the chi square test was made, (95% of confidence) (p ‹ 0.05). Results: Slow progressors (31 patients): OL-HIV = 22.5%, DFT/dft 5.15 ± 5.9, OHI 1.2 ± 0.4; Long term survivors (25 patients); OL-HIV 28%, DFT/dft 5.46 ± 5.3, OHI 1.1 ± 1.9. Pre-teenagers (15 patients): OL-HIV 40%, DFT/dft 5 ± 5, OHI 1.5 ± 0.5; Teenagers (10 Patients) OL-HIV 20%, DFT/dft 6.2 ± 4.8, OHI 1.9 ± 1.0. Eritematous oral candidiasis was the most prevalent finding in all the study groups. Conclusions: HIV+/AIDS long term survivors children show a high prevalence of oral lesions and dental-gingival characteristics that justified and increased in the surveillance of their oral health.


REFERENCES

  1. CONASIDA. El SIDA en cifras. dio: http://www.Conasida. gob.mx/el sida en cifras.

  2. Dirección general de estadística. Secretaría de salud. SIDA en Niños. Casos acumulados por edad y por sexo. dio: http://www.salud.gob.mx/conasida/stadistics/2007/porsexoyedad.pdf

  3. Scott GB, Hutto C, Makuch RW et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989; 321: 1791–1796.

  4. Nielsen K, McSherry G, Petru A et al. Descriptive survey of pediatric human immunodeficiency virus-infected long-term survivors pediatrics. 1997; 99: 4-10.

  5. Italian Register for HIV Infection in Children. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994; 343: 191–195.

  6. Blanche S, Tardieu M, Duliege A et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child 1990; 144: 1210–1215.

  7. Frederick T, Mascola L, Eller A et al. Progression of human immunodeficiency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Pediatr Infect Dis J 1994; 13: 1091–1097.

  8. Ceballos SA, Gaitán CLA. Asistencia odontológica a pacientes con infección por VIH. En: Bullon FP, Machuca PG, eds. Tratamiento odontológico en pacientes especiales. 2ª ed. Madrid: Laboratorios Normon; 2004.

  9. McComsey G, Bhumbra N, Ma JF et al. Impact of protease inhibitor substitution with efavirenz in HIV infected Children: Results of the first pediatric switch study. Pediatrics 2003; 111: e275-280.

  10. Moore R, Keruly J, Richman D et al. Natural history of advanced HIV disease in patients treated with zidovudine. AIDS 1992; 6: 671–676.

  11. Leggott P. Oral manifestations of HIV infection in children. Oral Surg Oral Med Oral Pathol 1992; 73: 187-92.

  12. Ketchem L, Berkowitz RJ, McIlveen L et al. Oral findings in HIV-seropositive children. Pediatr Dent 1990; 12: 143-146.

  13. Costa LR, Villena RS, Sucasas PS et al. Oral findings in pediatric AIDS; a case control study in Brazilian children. ASDC J Dent Child 1998; 65: 186-190.

  14. Ramos GF. Dental considerations for the paediatric AIDS/HIV patient. Oral Dis 2002; (Suppl 2): 49-54.

  15. Flaitz C, Wullbrandt B, Sexton J et al. Prevalence of urodental findings in HIV infected Romanian children. Pediatr Dent 2001; 23: 44-50.

  16. Expósito DAJ, Vallejo BE, Martos CEG. Manifestaciones orales de la infección por VIH en la infancia. Med Oral Patol Oral Cir Basal 2004; 9: 410-20.

  17. Chigurupati R, Raghavan SS, Studen-Pavlovich DA. Pediatric HIV infections and its oral manifestations: a review. Pediatr Dent 1996; 18: 106-13.

  18. Katz MH, Mastrucci MT, Leggott PJ et al. Prognostic significance of oral lesions in children with perinatally acquired human immunodeficiency virus infection. Am J Dis Child 1993; 147: 45-8.

  19. WHO. Global goals for oral health in the year 2000. FDI Int Dent J 1982; 32: 74-77.

  20. Melo NR, Taguchi H, Almeida OP et al. Oral candidiasis flora from brazilian immunodeficiency virus infected patients in highly active antiretroviral therapy era. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2004; 99: 425-431.

  21. Fonseca R, Cardoso A, Pomarico I. Frequency of oral manifestations in children with human immunodeficiency virus. Quintessence Int 2000; 31: 419-422.

  22. Diz P, Vázquez E, Feijoo JF et al. Patología oral en niños infectados por el virus de la inmunodeficiencia humana. Odontología Pediátrica 1994; 3: 12-18.

  23. Velasco E. Odontoestomatología y SIDA. Espaxs. 2002.

  24. Hoegl, Thoma- Greber E, Röcken M et al. HIV protease inhibitors influence the prevalence of oral candidiosis in HIV-infected patients: a 2-year study. Mycoses 1998; 41: 321-5.

  25. Ceballos-Salobreña A, Gaitán-Cepeda L, Ceballos-García L et al. The effect of anti-retroviral therapy on the prevalence of HIV-Associated oral candidiasis in a Spanish cohort. Oral Surg Oral Med Oral Pathol Radiol Endod 2004; 97: 345-50.

  26. Hoegl, Thoma-Greber E, Röcken M et al. Shift from persistent oral pseudomembranous to erythematous candidiosis in a human immunodeficiency virus (HIV)- infected patient upon combination treatment with an HIV protease inhibitor. Mycoses 1998; 41: 213-7.




2020     |     www.medigraphic.com